Serum metabonomics reveal the effectiveness of human placental mesenchymal stem cell therapy for primary sclerosing cholangitis

Abstract Background The metabolic patterns of human placental-derived mesenchymal stem cell (hP-MSC) treatment for primary sclerosing cholangitis (PSC) remain unclear, and therapeutic effects significantly vary due to individual differences. Therefore, it is crucial to investigate the serological re...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Yingduo Yu, Qigu Yao, Deying Chen, Zhehua Zhang, Qiaoling Pan, Jiong Yu, Hongcui Cao, Liang Li, Lanjuan Li
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2024-10-01
Saila:	Stem Cell Research & Therapy
Gaiak:	Mesenchymal stem cell Metabolomics Mdr2−/− mouse Primary sclerosing cholangitis Chemical isotope-labeled liquid chromatography-mass spectrometry Efficacy biomarker
Sarrera elektronikoa:	https://doi.org/10.1186/s13287-024-03967-y
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!